Baseline visit Day 0 | Visit 1 Day 1 | Visit 2 Day 15 | Visit 3 Day 30 | Visit 4 Day 45 | Visit 5 Day 60 | Visit 6 Day 75 | Visit 7 Day 90 End of follow-up | |
---|---|---|---|---|---|---|---|---|
Verification of inclusion criteria | x | |||||||
Patient has signed the informed consent | x | |||||||
Randomisation | x | |||||||
Intervention | x | x | x | x | x | x | x | |
Resverch assessment | x | x | x | x | x | x | x | |
CCVUQ-e questionnaire | x | x | ||||||
Collecting data on adverse reactions | x | x | x | x | x | x | ||
Healing complete | x | x | x | x | x | x | ||
Sociodemographic variables | x | |||||||
Prognostic variables | x | |||||||
Variables related to healing | x | x | x | x | x | x | x |